{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/gastroenteritis/prescribing-information/tinidazole/","result":{"pageContext":{"chapter":{"id":"a6969159-fdcf-5f1f-ac9a-c8bcf291abdc","slug":"tinidazole","fullItemName":"Tinidazole","depth":2,"htmlHeader":"<!-- begin field 7b57e67b-77ed-4ba6-810e-e70b3f08fd66 --><h2>Tinidazole</h2><!-- end field 7b57e67b-77ed-4ba6-810e-e70b3f08fd66 -->","summary":"","htmlStringContent":"<!-- begin item 37f181b9-b428-415c-87ac-b4c4638adb93 --><!-- end item 37f181b9-b428-415c-87ac-b4c4638adb93 -->","topic":{"id":"b4861e4a-0cf5-5fed-b83a-a57e60b78a80","topicId":"f3241704-6943-4c6f-9689-cf06812d0832","topicName":"Gastroenteritis","slug":"gastroenteritis","lastRevised":"Last revised in August 2020","chapters":[{"id":"6d884ff2-d64b-55ab-aae4-78f940a95f30","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"2b8c6f38-638e-5804-8318-e1b14304e522","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"94101b20-12cb-5041-a413-6dcc12af895e","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"f4287eb4-029e-5263-ae00-6b8ece9aff32","slug":"changes","fullItemName":"Changes"},{"id":"4d578aaa-9662-5914-903d-e36514be32a0","slug":"update","fullItemName":"Update"}]},{"id":"d01dac38-120c-51d7-a620-b85d40b1eb15","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"cd1552a6-5a2d-563b-a242-29bd94992517","slug":"goals","fullItemName":"Goals"},{"id":"b7b0c03c-8588-5565-82d9-9cfe2d111d41","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"b32a632a-610d-59de-bf5f-d79f466a66b7","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"28e54d5a-177d-5e18-9753-67134efb41a6","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"2b2f62eb-7996-5b9c-88ed-3648b2e3721d","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"1e2a0d5e-dba9-54fe-99e1-1e33dd814faa","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"d382f491-ad27-5dbc-bfa7-806501a73eb5","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"c6b1334e-cda3-5363-a887-f24bcde0b626","slug":"definition","fullItemName":"Definition"},{"id":"501c659b-1656-5ad1-b381-f3042ed81bec","slug":"causes","fullItemName":"Causes"},{"id":"2e6d28a0-305f-5c3c-983a-62e1631c41b8","slug":"complications","fullItemName":"Complications"}]},{"id":"71e06d5f-9179-5a88-986f-34fd82eab600","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"de24a8b0-cda2-5be8-8fbf-df6ddf6fb6eb","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"3f17076e-616a-532c-a5ee-d6a5d2104dc5","slug":"assessment","fullItemName":"Assessment"},{"id":"bf8cbeb8-b0a5-5ebc-9cfc-7ba3beb62c6b","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"34db7d00-7fa0-5e11-a2b2-0e045c80e236","fullItemName":"Management","slug":"management","subChapters":[{"id":"64ea9cd1-ae9b-5d77-bc7b-1df0c42b3d66","slug":"child-gastroenteritis","fullItemName":"Scenario: Child gastroenteritis"},{"id":"97ae699a-60c4-5649-a4ad-f0bbdf5c7aa5","slug":"adult-gastroenteritis","fullItemName":"Scenario: Adult gastroenteritis"}]},{"id":"3874a053-755a-5518-961d-b6811d36d278","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"a6969159-fdcf-5f1f-ac9a-c8bcf291abdc","slug":"tinidazole","fullItemName":"Tinidazole"},{"id":"ddc9423c-8dd0-5c5b-b208-f261c2cd777d","slug":"clarithromycin","fullItemName":"Clarithromycin"}]},{"id":"84f507dc-726d-559a-b788-9c91297b0fd0","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"2e6aa3b5-4c48-538f-bc1e-8c97a0e4940e","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"60c6fc26-4bfa-5e0d-bba6-0ebffc61d83b","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"0cb4826a-19bb-549f-b65f-2f5ad75883bc","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b05f7822-56ab-538c-9fb0-fd20a99810a2","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"8bc3886a-0fd7-52a0-9be2-506de8584bc9","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"a0898f71-226b-5af6-87b5-20b9c6c1fe78","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"a52fa5fd-99e9-5dd5-b626-0e429b2424e3","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"3874a053-755a-5518-961d-b6811d36d278","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"ff672948-a0f3-52ad-883a-51ad118b6cc2","slug":"contraindications-cautions","fullItemName":"Contraindications and cautions","depth":3,"htmlHeader":"<!-- begin field 8b728e71-cc1b-4c19-9dc4-ac1200df639e --><h3>Contraindications and cautions</h3><!-- end field 8b728e71-cc1b-4c19-9dc4-ac1200df639e -->","summary":"","htmlStringContent":"<!-- begin item 8da27b03-6d78-4268-9301-ac1200df632b --><!-- begin field c161843f-d8b3-44cd-8441-ac1200df639e --><ul><li><strong>Do not prescribe tinidazole to:</strong><ul><li>Pregnant women in the first trimester — the manufacturer advises to avoid.</li></ul></li><li><strong>Prescribe tinidazole with caution to:</strong><ul><li>Women who are breastfeeding — the manufacturer advises to avoid breastfeeding during and for 3 days after stopping treatment.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Joint Formulary Committee, 2020</a>]</p><!-- end field c161843f-d8b3-44cd-8441-ac1200df639e --><!-- end item 8da27b03-6d78-4268-9301-ac1200df632b -->","subChapters":[]},{"id":"0ce1fb23-a78c-5fc4-bd08-ccac17a6819f","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field df12d28b-4db6-462d-aaa0-ac1200df780f --><h3>Adverse effects</h3><!-- end field df12d28b-4db6-462d-aaa0-ac1200df780f -->","summary":"","htmlStringContent":"<!-- begin item 847dd353-eed7-4bdd-b2ce-ac1200df77ec --><!-- begin field 986c3f5b-bded-4286-88d8-ac1200df780f --><p><strong>Possible adverse effects of tinidazole include:</strong></p><ul><li>Abdominal pain, decreased appetite, diarrhoea, headache, nausea, skin reactions, vertigo, and vomiting.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Joint Formulary Committee, 2020</a>]</p><!-- end field 986c3f5b-bded-4286-88d8-ac1200df780f --><!-- end item 847dd353-eed7-4bdd-b2ce-ac1200df77ec -->","subChapters":[]},{"id":"a9957190-0ca9-5abf-a399-46eac9b8ce73","slug":"drug-interactions","fullItemName":"Drug interactions","depth":3,"htmlHeader":"<!-- begin field 6c6c9a6b-cfdd-4fb9-8796-ac1200df8666 --><h3>Drug interactions</h3><!-- end field 6c6c9a6b-cfdd-4fb9-8796-ac1200df8666 -->","summary":"","htmlStringContent":"<!-- begin item 834cd251-3084-43a5-bcb4-ac1200df8643 --><!-- begin field b02e4da0-d323-42d3-b738-ac1200df8666 --><p><strong>Possible drug interactions of tinidazole include:</strong></p><ul><li>Alcohol — alcohol potentially causes a disulfiram-like reaction when given with tinidazole. The manufacturer advises to avoid for 72 hours after stopping treatment.</li><li>Warfarin — tinidazole is predicted to increase the anticoagulant effect of warfarin. The manufacturer advises to monitor the international normalised ratio (INR) and adjust the dose accordingly.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Joint Formulary Committee, 2020</a>] </p><!-- end field b02e4da0-d323-42d3-b738-ac1200df8666 --><!-- end item 834cd251-3084-43a5-bcb4-ac1200df8643 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}